{
  "title": "Periodic Transaction Report for 12/06/2017",
  "filer": "The Honorable Michael D Crapo (Crapo, Michael D.)",
  "filedDate": "Filed 12/06/2017 @ 5:30 PM",
  "data": [
    {
      "heading": "Transactions",
      "rows": [
        {
          "#": "1",
          "Transaction Date": "11/27/2017",
          "Owner": "Joint",
          "Ticker": "--",
          "Asset Name": "Pharma Partners, LLC\n                                        \n                                        \n                                        \n                                            \n                                                \n                                                    Company: Pharma Partners, LLC\n                                                    \n                                                         (Englewood, CO)\n                                                    \n                                                \n                                            \n\n                                            \n                                                Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001.",
          "Asset Type": "Other Securities",
          "Type": "Purchase",
          "Amount": "$50,001 - $100,000",
          "Comment": "Investment in LLC."
        }
      ]
    }
  ]
}